The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 20232028
” " the global drug screening market reached a value of US$ 6.0 Billion in 2022.
A drug screening or a drug test is the collection and analysis of blood, hair, urine, or saliva to detect the presence of chemicals and contaminants in the body due to drug consumption or use. It is also used to detect performance-improving drugs, such as steroids and HGH, which are sometimes used by athletes. There are different types of drug screening, such as urine drug screening, saliva drug screening, blood drug screening, and hair testing. Various corporates also conduct it to ensure a safe workplace for the employees. Its primary applications are employers screening for drugs prohibited by law and police officers testing for the presence and concentration of alcohol in the blood. Drug detection depends upon various factors, such as age, amount and frequency of use, body mass, drug class, metabolic rate, overall health, and urine pH.
Request Free Sample Report: https://www.imarcgroup.com/drug-screening-market/requestsample
The global market is majorly driven by the increasing incidences of illegal drugs consumptions. In line with this, the rising prevalence of drug addiction and the growing crime rates associated with drug abuse are significantly contributing to the market growth. Furthermore, various stringent regulations by government agencies mandating alcohol and drug screening for safety purposes are positively influencing the market. Apart from this, the growing initiatives by the governments to monitor and combat substance abuse are creating a positive outlook for the market.
Moreover, the increasing alcohol use among adolescents and the senior population, overuse of prescribed pharmaceuticals, and the growing use of opioids and illegal drugs are catalyzing the market. Besides, the rapid adoption of drug screening products and services on the road to avoid drink-and-drive cases is propelling the market. Some of the other factors driving the market include the escalating road accidents due to overdose of drugs, continual product launches and services, and the increasingly unlawful use of steroids by professional athletes. On account of the factors above, the market is anticipated to reach a value of US$ 9.8 Billion by 2028, exhibiting a CAGR of 7.6% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Market Summary:
Product and Service Insights:
• Equipment
• Immunoassay Analyzers
• Chromatography Instruments
• Breath Analyzers
• Rapid Testing Devices
• Urine Testing Devices
• Oral Fluid Testing Devices
• Consumables
• Assay Kits
• Sample Collection Cups
• Calibrators and Controls
• Others
• Laboratory Services
Sample Type Insights:
• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Others
End User Insights:
• Hospitals
• Drug Testing Laboratories
• Workplaces
• Drug Treatment Centers
• Pain Management Centers
• Personal Users
• Criminal Justice System and Law Enforcement Agencies
Regional Insights:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
Competitive Landscape with Key Players:
• Abbott Laboratories
• Alfa Scientific Designs Inc.
• Bio-Rad Laboratories Inc.
• Drägerwerk AG & Co. KGaA
• Laboratory Corporation of America Holdings
• Lifeloc Technologies Inc.
• Omega Laboratories Inc.
• OraSure Technologies Inc.
• Psychemedics Corporation
• Quest Diagnostics Incorporated
• Siemens AG
• Thermo Fisher Scientific Inc.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/drug-screening-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
